Cargando…
Glucose-Lowering Medications and Post-Dementia Survival in Patients with Diabetes and Dementia
BACKGROUND: The effectiveness of glucose-lowering drugs (GLDs) is unknown among patients with dementia. OBJECTIVE: To analyze all-cause mortality among users of six GLDs in dementia and dementia-free subjects, respectively. METHODS: This was a longitudinal open-cohort registry-based study using data...
Autores principales: | Secnik, Juraj, Xu, Hong, Schwertner, Emilia, Hammar, Niklas, Alvarsson, Michael, Winblad, Bengt, Eriksdotter, Maria, Garcia-Ptacek, Sara, Religa, Dorota |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028644/ https://www.ncbi.nlm.nih.gov/pubmed/35034902 http://dx.doi.org/10.3233/JAD-215337 |
Ejemplares similares
-
Cholinesterase inhibitors in patients with diabetes mellitus and dementia: an open-cohort study of ~23 000 patients from the Swedish Dementia Registry
por: Secnik, Juraj, et al.
Publicado: (2020) -
The association of antidiabetic medications and Mini-Mental State Examination scores in patients with diabetes and dementia
por: Secnik, Juraj, et al.
Publicado: (2021) -
Dementia Diagnosis Is Associated with Changes in Antidiabetic Drug Prescription: An Open-Cohort Study of ∼130,000 Swedish Subjects over 14 Years
por: Secnik, Juraj, et al.
Publicado: (2020) -
TREATMENT WITH ANTIPSYCHOTICS AND RISK OF DEATH IN 58,000 PATIENTS FROM SWEDISH DEMENTIA REGISTRY
por: Religa, Dorota, et al.
Publicado: (2019) -
Biting the Bullet: Firearm Ownership in Persons with Dementia. A Registry-Based Observational Study
por: Schwertner, Emilia, et al.
Publicado: (2021)